Literature DB >> 30755138

Proteomic Analysis Reveals Temporal Changes in Protein Expression in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes In Vitro.

Nicola Hellen1, Carolina Pinto Ricardo1, Karine Vauchez1, Gail Whiting2, Jun X Wheeler2, Sian E Harding1.   

Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) hold great promise for regenerative medicine and in vitro screening. Despite displaying key cardiomyocyte phenotypic characteristics, they more closely resemble fetal/neonatal cardiomyocytes, and further characterization is necessary. By combining the use of tandem mass tags to label cell lysates, followed by multiplexing, we have determined the effects of short-term (30 day) in vitro culture on hiPSC-CM protein expression. We found that hiPSC-CM exhibit temporal changes in global protein expression; alterations in protein expression were pronounced during the first 2 weeks following thaw and dominated by reductions in proteins associated with protein synthesis and ubiquitination. Between 2 and 4 weeks, proceeding thaw alterations in protein expression were dominated by metabolic pathways, indicating a potential temporal metabolic shift from glycolysis toward oxidative phosphorylation. Time-dependent changes in proteins associated with cardiomyocyte contraction, excitation-contraction coupling, and metabolism were detected. While some were associated with expected functional outcomes in terms of morphology or electrophysiology, others such as metabolism did not produce the anticipated maturation of hiPSC-CM. In several cases, a predicted outcome was not clear because of the concerted changes in both stimulatory and inhibitory pathways. Nevertheless, clear development of hiPSC-CM over this time period was evident.

Entities:  

Keywords:  cardiomyocyte; pluripotent; proteomics

Mesh:

Substances:

Year:  2019        PMID: 30755138     DOI: 10.1089/scd.2018.0210

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  8 in total

1.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome.

Authors:  D Kent Arrell; Christian S Rosenow; Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  NPJ Regen Med       Date:  2020-03-12

2.  A Proteomic Perspective on Cardiomyocyte Maturation.

Authors:  Naoto Muraoka; Bingyun Sun; Charles E Murry
Journal:  Circ Res       Date:  2019-11-07       Impact factor: 17.367

Review 3.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Authors:  Elaheh Karbassi; Aidan Fenix; Silvia Marchiano; Naoto Muraoka; Kenta Nakamura; Xiulan Yang; Charles E Murry
Journal:  Nat Rev Cardiol       Date:  2020-02-03       Impact factor: 32.419

Review 4.  Enhancing Matured Stem-Cardiac Cell Generation and Transplantation: A Novel Strategy for Heart Failure Therapy.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Kai Yin; Shiyin Long
Journal:  J Cardiovasc Transl Res       Date:  2020-11-30       Impact factor: 4.132

5.  NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes.

Authors:  Xinyuan Zhang; Liang Ye; Hao Xu; Qin Zhou; Bin Tan; Qin Yi; Liang Yan; Min Xie; Yin Zhang; Jie Tian; Jing Zhu
Journal:  Stem Cell Res Ther       Date:  2021-03-24       Impact factor: 6.832

6.  Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells.

Authors:  Sundararajan Venkatesh; Erdene Baljinnyam; Mingming Tong; Toshihide Kashihara; Lin Yan; Tong Liu; Hong Li; Lai-Hua Xie; Michinari Nakamura; Shin-Ichi Oka; Carolyn K Suzuki; Diego Fraidenraich; Junichi Sadoshima
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-28       Impact factor: 3.619

7.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome.

Authors:  D Kent Arrell; Christian S Rosenow; Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  NPJ Regen Med       Date:  2020-03-12

Review 8.  Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy.

Authors:  Jarrod Moore; Andrew Emili
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.